Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. provided earnings guidance for 2019. For the period, the company based on preliminary statistics of its financial department, the Company expects that it will turn losses into gains in its the net profit belonging to shareholders of the listed company in 2019 compared with the same period of the year before, with the net profit belonging to shareholders of the listed company to be between RMB 21,000,000 and RMB 30,000,000. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between negative RMB 43,000,000 and negative RMB 34,000,000.